Navigation Links
Diagnostic Center for Disease: Prostate Biopsy Spreads Prostate Cancer Cells
Date:2/19/2008

SARASOTA, Fla., Feb. 19 /PRNewswire/ -- Breaking news from the Diagnostic Center for Disease(TM) in Sarasota, Florida, identifies a previously underestimated risk that routine prostate biopsy performed to evaluate for prostate cancer spreads cancer cells and may be the reason that men have a recurrence of disease many years after the prostate was removed successfully with clear surgical margins. Traditionally, an ultrasound and prostate biopsy is commonly recommended and performed by Urologists when a patient presents with a prostate specific antigen (PSA) of 2.5 ng/ml or above. Men have been told for years that the procedure is safe and the only way to diagnose prostate cancer. While this paradigm represents the current standard, the system exposes far too many men to needless biopsies; as the number one reason PSA rises is prostatitis, not prostate cancer. Still other men may have a small cancer that is missed based on the inability of this standard procedure to target a suspected lesion in question (sampling error). Regardless of the rationale for a biopsy, all men suffer the potential risk for bleeding, scarring, infection or sepsis and needless intrusion that has reportedly resulted in impotency and/or incontinence in some patients. A more important issue that is often not discussed between physician and patient involves the possibility of "needle tracking", the very real possibility of spreading cancer cells beyond the prostate when a biopsy is performed. An extensive review of the literature confirms that once a needle penetrates the capsule of an organ, a phenomenon called "needle tracking" takes place. When the needle is withdrawn from the targeted organ, the chance of spreading cancer cells (when encountered) establishes itself, and every puncture of the prostate adds to this risk. Despite the significance of this risk to the patient, physicians generally fail to acknowledge a process that allows cells to lie dormant or incubate for up to 10 years o
'/>"/>

SOURCE Diagnostic Center for Disease
Copyright©2008 PR Newswire.
All rights reserved

8

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
2. Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children
3. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
4. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
5. Abbotts m2000(TM) Molecular Diagnostic Instrument and RealTime HIV-1 Test Win Chicago Innovation Award
6. Roche Diagnostics HIV Viral Load Test Used in Clinical Trials for Isentress, a New Class of HIV Drug
7. Two Point of Care Tests From Quest Diagnostics Receive FDA 510(k) Clearance
8. Imaging Diagnostic Systems CTLM Technology Presented at Congress of World Society for Breast Health
9. Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease
10. Xenomics Announces Issuance of a US Patent That Covers Use of Transrenal Nucleic Acid Technology for Infectious Disease Diagnostics and Monitoring
11. Imaging Diagnostic Systems Updates PMA Filing Status for the New CT Laser Breast Imaging System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... YORK , LONDON , ... , May 20, 2013 ... of Osteoarthritis and Preference for Minimally Invasive Procedures to ... landscape, and market trends for the six arthroscopy device ... (FMSs), arthroscopy implants, arthroscopy radio frequency systems, and arthroscopy ...
(Date:5/20/2013)... announced today the presentation of results from a new ... among diabetic patients in the U.S. than previously recognized. ... both type 1 and type 2 diabetes, but this ... common type 2 disease. Lee ... Medicine at Harvard Medical School and Director of the ...
(Date:5/20/2013)... CHICAGO, Ill. , May 20, 2013 /PRNewswire/ ... the initiation of a Phase 3 clinical study ... to assess the effects of the investigational compound ... progression of kidney disease in patients with stage ... type 2 diabetes.  SONAR is a large, multinational, ...
Breaking Medicine Technology:Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 2Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 3Increasing Prevalence of Osteoarthritis and Preference for Minimally Invasive Procedures to Drive Arthroscopy Devices Market Growth 4Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 2Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 3Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 4AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 2AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 3AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 4AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 5AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 6
... Medical Tactile, Inc. and Valentus Medical Technologies, Inc. ... , Canada , has signed a partnership agreement with Medical Tactile, ... SureTouch™ , the non-invasive digital breast imaging technology, worldwide, with the ... , , ...
... July 13 Amira Pharmaceuticals, Inc. today announced that the ... Activating Protein (FLAP) Inhibitors," which includes coverage of Amira,s AM103 and ... , , ... , Amira and GlaxoSmithKline (GSK) entered into a worldwide exclusive agreement ...
Cached Medicine Technology:Partnership Brings Breast Image Documentation Technology to Women Around the World 2Amira Announces AM103 and AM803 Patent Grant in the United Kingdom 2
(Date:5/20/2013)... new Canadian study has uncovered an apparent gender bias ... men to get trauma center care following a severe ... services in general have been recognized for some time, ... the treatment of severe injuries in trauma centers," study ... Sciences Centre and the University of Toronto, said in ...
(Date:5/20/2013)... in Sweden have mapped the significance of heredity ... have previously examined whether different forms of the ... heart disease, ischemic stroke, peripheral arterial disease and ... and parents have suffered different types of cardiovascular ... highest for atherosclerosis of the aorta followed by ...
(Date:5/20/2013)... Plains, NY (PRWEB) May 20, 2013 ... firm of Levy Phillips & Konigsberg LLP ... Street in White Plains, New York. LPK will better ... in the Hudson Valley, including Westchester, Putnam, Rockland, Orange, ... helping families affected by asbestos-related diseases throughout New York, ...
(Date:5/20/2013)... as a consequence of diabetic foot ulcer that does ... this situation are very limited. In his doctoral thesis ... Department of Medical Biochemistry and Biophysics at Ume University ... may completely change the lives of millions of patients. ... chronic wounds that largely impair the quality of life ...
(Date:5/20/2013)... May 20, 2013 The producers of ... to the essentials of home schooling. It will educate viewers ... need to assist children in reaching educational goals. Most homes ... basic needs in education. Instructors can send tests to state ... the Web. The celebrity-hosted segment is a top-notch guide for ...
Breaking Medicine News(10 mins):Health News:Women Less Likely to Get Trauma Center Care After Injury: Study 2Health News:Westchester Mesothelioma Lawyers Open Office in White Plains, New York 2Health News:Westchester Mesothelioma Lawyers Open Office in White Plains, New York 3Health News:Discovery of a novel medicine for the treatment of chronic wounds 2Health News:Editions TV Presents a Home School Essentials Segment 2
... Support NIH Information Sharing and Collaboration ServicesCHANTILLY, Va., ... region,s leading providers of government professional technical solutions, ... by the National Institutes of Health (NIH) for ... February 18, 2009, covers a one year period ...
... 25 AdaptaVan, LLC has announced partnerships with ... of its customized wheelchair-accessible vans throughout ... Emmett Koelsch Coaches, Inc. of Oregon City, Ore.; ... Conn.; Superior Chevrolet, Inc. of Cincinnati, Ohio; Autotronics ...
... Cancer Center have developed an assay that may be ... a predisposition to cancer. , The study, published in ... done in yeast and mammalian cells. , Cancer cells ... Robert Schiestl, have discovered a mechanism that switches on ...
... LONDON, March 25 Clinica - the world,s leading medical,technology ... state of,asbestos regulation in the UK, in light of discrepancies ... Westminster. , On the day of ... latest developments in Clinica,s investigation into the extent,of the problem ...
... March 25 Abbott ( NYSE: ABT ) will announce ... before the market opens.The announcement will be followed by a ... Central time (9 a.m. Eastern), and will be accessible through ... An archived edition of the call will be available after ...
... Physicians Practice and Rose Medical Center have joined forces ... time to devote to patient care. This new partnership ... the Denver Metro Area better handle the cumbersome and ... new alliance, Rose Medical Center will use Physicians Practice,s ...
Cached Medicine News:Health News:NIH Awards Blanket Purchase Agreement (BPA) to Citizant 2Health News:AdaptaVan, LLC Expands National Availability of Wheelchair-Accessible Vans 2Health News:Discovery may result in new test to determine predisposition to cancer 2Health News:Discovery may result in new test to determine predisposition to cancer 3Health News:Westminster Safety Disagreement Highlights Risk in Schools 2Health News:Westminster Safety Disagreement Highlights Risk in Schools 3Health News:Physicians Practice and Rose Medical Center Partner to Improve Patient Care in the Denver Metro Area 2Health News:Physicians Practice and Rose Medical Center Partner to Improve Patient Care in the Denver Metro Area 3
Stainless steel flexible ruler. graduated in 1/32 inches (.8 mm) fractions, as well as mm graduations....
Colorado Microneedles offer the surgeon precision in cutting and coagulation, without the expense and inconvenience of a laser. The needles may also be used for dissecting large areas such as the sca...
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Medicine Products: